{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:42:47Z","timestamp":1776210167375,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euros.2026.02.009","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:01:06Z","timestamp":1771678866000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7216-1033","authenticated-orcid":false,"given":"Richard","family":"Weiten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Tolkach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Stehle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Glas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Keyvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Kl\u00fcmper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.02.009_b0005","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/cancers16203437","article-title":"Brain metastases from genito-urinary cancers in the canton of Geneva (Switzerland): study of incidence, management and outcomes","volume":"16","author":"Gonnet","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.euros.2026.02.009_b0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/BLC-200304","article-title":"Review: brain metastases in bladder cancer","volume":"6","author":"Brenneman","year":"2020","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.euros.2026.02.009_b0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0020","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1158\/2159-8290.CD-24-0708","article-title":"The Journey of antibody-drug conjugates: lessons learned from 40 years of development","volume":"14","author":"Colombo","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.euros.2026.02.009_b0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.02.009_b0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.02.009_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-023-00756-z","article-title":"Understanding the activity of antibody\u2013drug conjugates in primary and secondary brain tumours","author":"Mair","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0040","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/neuonc\/noae123","article-title":"Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases","volume":"26","author":"Bartsch","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/ph16030375","article-title":"First evidence of activity of enfortumab vedotin on brain metastases in urothelial cancer patients","volume":"16","author":"Vulsteke","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.euros.2026.02.009_b0050","article-title":"NECTIN4 amplification is frequent in solid tumors and predicts enfortumab vedotin response in metastatic urothelial cancer","author":"Kl\u00fcmper","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0055","first-page":"S1600","article-title":"3087P NECTIN4 amplification as a predictive biomarker of response to enfortumab vedotin plus pembrolizumab in first-line metastatic urothelial carcinoma: a multicenter cohort study","volume":"36","author":"Kl\u00fcmper","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100928","article-title":"Defining NECTIN4 amplification and protein expression in urothelial carcinoma and histologic subtypes","volume":"39","author":"Cheville","year":"2026","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euros.2026.02.009_b0065","article-title":"Abstract P4-10-21: Enhanced anti-tumor activity of zelenectide pevedotin in triple negative breast cancer (TNBC) patients (pts) with NECTIN4 gene amplification (amp)","volume":"31(12 S**uppl)","author":"Kl\u00fcmper","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euros.2026.02.009_b0070","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1556-0864(25)00291-6","article-title":"96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)","volume":"20(3 S**uppl 1)","author":"Verlingue","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.euros.2026.02.009_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.eururo.2022.10.020","article-title":"Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition","volume":"83","author":"Erlmeier","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.02.009_b0080","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/cancers17091591","article-title":"Exploring the role of ADCs in brain metastases and primary brain tumors: insight and future directions","volume":"17","author":"Bruzzone","year":"2025","journal-title":"Cancers"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:44:08Z","timestamp":1776206648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"alternative-id":["S2666168326000418"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.02.009","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}